HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor.

Abstract
The immunoreactive (RIA), ACTH, LPH, alpha endorphin (alpha End) and beta End in an extract of a human pancreatic islet cell carcinoma causing the ectopic ACTH syndrome were assayed after gel exclusion chromatography. In addition to "big", "intermediate" and "little" ACTHs, beta lipotropin (beta LPH) and gamma LPH, the eluate fractions contained RIA-alpha End and -beta End. The major RIA-beta End component appeared to be h beta LPH, which has beta End as its carboxy-terminus, but significant concentrations of a component that coeluted with synthetic p beta End were also found. Small amounts of RIA-alpha End were found in two peaks, one that may have represented 1-76 h beta LPH, with alpha End as its carboxy-terminus, and one probably representing alpha End itself. RIA-ACTH, -LPH and -beta End were found in the void volume fractions. Thus, a human nonpituitary tumor that produced ACTH and LPHs also produced endorphins, all perhaps deriving from a common precursor.
AuthorsD N Orth, R Guillemin, N Ling, W E Nicholson
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 46 Issue 5 Pg. 849-52 (May 1978) ISSN: 0021-972X [Print] United States
PMID233636 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endorphins
  • Protein Precursors
  • Adrenocorticotropic Hormone
  • beta-Lipotropin
Topics
  • Adenoma, Islet Cell (analysis)
  • Adrenocorticotropic Hormone (analysis)
  • Chromatography, Gel
  • Endorphins (analysis)
  • Humans
  • Pancreatic Neoplasms (analysis)
  • Protein Precursors (analysis)
  • Radioimmunoassay
  • beta-Lipotropin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: